<DOC>
	<DOCNO>NCT01958775</DOCNO>
	<brief_summary>1 . To assess whether Glucagon like peptide 2 ( GLP-2 ) affect lipoprotein production ( study A ) 2 . To assess whether GLP-2 affect release preform chylomicron ( study B )</brief_summary>
	<brief_title>Regulation Intestinal Hepatic Lipoprotein Production Glucagon Like Peptide 2</brief_title>
	<detailed_description>Study A : Using constant feeding nasoduodenal tube stable isotope infusion , mathematical modelling utilised measure lipoprotein production clearance . The lipoprotein assess apoB-100 liver apoB-48 intestine . StudyB : Volunteers give liquid meal retinyl palmitate ( vitamin A ) label chylomicron make meal . 7 hour later give GLP-2 placebo . Measurements plasma TRL ( triglyceride rich lipoprotein ) triglyceride TRL retinyl palmitate carry see whether GLP-2 increase parameter .</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>1 . Men woman , age 18 60 year 2 . Body mass index 20 kg/m2 30 kg/m2 3 . Hemoglobin 130g/L . 4 . Normal glucose tolerance response 75g , 2hr oral glucose tolerance test ( OGTT ) 1 . Subject history hepatitis/hepatic disease active within previous two year . 2 . Any significant active ( past 12 month ) disease gastrointestinal , pulmonary , neurological , renal ( Cr &gt; 1.5 mg/dL ) , genitourinary , hematological system , severe uncontrolled treated untreated hypertension ( sit diastolic BP &gt; 100 systolic &gt; 180 ) proliferative retinopathy 3 . History diabetes OGTT indicative diabetes impair glucose tolerance . 4 . Any history ischemic heart disease clinically significant , active , cardiovascular history include history arrhythmia 's conduction delay ECG , unstable angina , decompensated heart failure . 5 . Abnormal liver thyroid function test 6 . Current addiction alcohol substance abuse determine investigator . 7 . Mental incapacity , unwillingness language barrier preclude adequate understanding cooperation 8 . Taking prescription nonprescription medication time study 9 . Having donate blood three month prior three month post study procedures 10 . A pregnancy test perform 1 3 day prior study female research participant . Those test positive pregnancy exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Lipoproteins , apoB , GLP-2</keyword>
</DOC>